Form 4 for BDSX BIODESIX INC
Accepted 2023-04-04 00:00:00 ET · period of report 2023-03-31 · accession 0001140361-23-016261 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-04 | 2023-03-31 | BDSX | Kayyem Jon Faiz | Dir | M - OptEx | — | +145.8K | 177.5K | +461% | — |
| D | 2023-04-04 | 2023-03-31 | BDSX | Kayyem Jon Faiz | Dir | M - OptEx | $0.00 | -145.8K | 4,878 | -97% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | M | A | 145,833 | — | 177,452 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. |
| 2 | Derivative | Restricted Stock Units | 2023-03-31 | M | D | 145,833 | $0.00 | 4,878 | D | — · — to — | 145,833 Common Stock | (F4) This amount includes 4,878 deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service to the Issuer. (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. (F3) These RSUs vested in full on March 31, 2023. |